Loading…
Loading…
Wellgistics Health (NASDAQ: MEDS - Get Free Report) and CorVel (NASDAQ: CRVL - Get Free Report) are both healthcare companies, but which is the better business? We will compare the two companies based on the strength of their risk, valuation, institutional ownership, earnings, analyst recommendations, dividends and profitability. Earnings and Valuation This table compares Wellgistics Health and
Assenagon Asset Management S.A. reduced its stake in CorVel Corp. (NASDAQ: CRVL) by 48.5% during the second quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 101,952 shares of the business services provider's stock after selling 95,906 shares during the period.
CorVel Corporation (CRVL) Q1 2027 Earnings Call Prepared Remarks Transcript
CorVel NASDAQ: CRVL reported June-quarter revenue of $260 million, up 11% from $235 million in the June 2025 quarter, while earnings per share rose 22% to $0.63 from $0.52 a year earlier.
FORT WORTH, Texas, Aug. 05, 2026 (GLOBE NEWSWIRE) -- CorVel Corporation (NASDAQ: CRVL) announced the results for the quarter ended June 30, 2026. Revenues for the quarter were $260 million, an increase from $235 million in the June quarter of 2025. Earnings per share for the quarter were $0.63, compared to $0.52 in the same quarter of the prior year.
FORT WORTH, Texas, July 27, 2026 (GLOBE NEWSWIRE) -- CorVel Corporation (NASDAQ: CRVL), a leading provider of innovative risk management solutions, is pleased to announce that it will host a live webcast to discuss its upcoming quarterly earnings results on Wednesday, August 5, 2026, at 11:30 AM Eastern Time.
CorVel earned the 2026 PropertyCasualty360 Insurance Luminaries Award for Excellence in Claims Management for its integrated, technology-enabled approach.
FORT WORTH, Texas, June 17, 2026 (GLOBE NEWSWIRE) -- CorVel Corporation (Nasdaq: CRVL), a national provider of risk management solutions, today announced the launch of CorVel Marketwise Repricing™, a market-based medical bill repricing solution designed to enhance cost containment while fitting seamlessly into existing bill review programs. As medical billing continues to vary widely across states, providers, and care settings, traditional network and re-pricing approaches do not always reflect market pricing.